Anti-Synthetase Syndrome clinical trials at UCSF
1 research study open to eligible people
Anti-synthetase syndrome is a condition affecting muscles and lungs due to improper immune response. UCSF is researching new treatments to improve care for inflammatory muscle diseases. Current clinical trials are open for people with idiopathic or juvenile inflammatory myopathy.
Showing trials for
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
open to eligible people ages 6-75
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
San Francisco, California and other locations
Our lead scientists for Anti-Synthetase Syndrome research studies include Susan Kim, MD, MMSc.
Last updated: